Skip to main content
SpringerLink
Log in

Journal Club

  • JOURNAL CLUB
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238–48.

    Article  CAS  PubMed  Google Scholar 

  2. Fellström BC, Jardine AG, Schmieder RE, et al., AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395–407.

    Article  PubMed  Google Scholar 

  3. Baigent C, Keech A, Kearney PM, et al., Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.

    Article  CAS  PubMed  Google Scholar 

  4. Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 2001;38:Suppl 1:S26–9.

    Article  CAS  PubMed  Google Scholar 

  5. Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007;116:1465–72.

    Article  PubMed  Google Scholar 

  6. Baigent C, Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int Suppl 2003;84:S207–10.

    Article  PubMed  Google Scholar 

Literatur

  1. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953–62.

    Article  PubMed  Google Scholar 

  2. Textor SC. Renovascular hypertension in 2007: where are we now? Curr Cardiol Rep 2007;9:453–61.

    Article  PubMed  Google Scholar 

  3. Wierema TK, Yaqoob MM. Renal artery stenosis in chronic renal failure: caution is advised for percutaneous revascularization. Eur J Intern Med 2008;19:276–9.

    Article  PubMed  Google Scholar 

  4. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003;18:298–304.

    Article  PubMed  Google Scholar 

  5. Plouin PF, Rossignol P, Bobrie G. Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate? J Am Soc Nephrol 2001;12:2190–6.

    CAS  PubMed  Google Scholar 

  6. van Jaarsveld BC, Krijnen P, Pieterman H, et al., Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med 2000;342:1007–14.

    Article  PubMed  Google Scholar 

  7. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823–9.

    CAS  PubMed  Google Scholar 

  8. van Jaarsveld B, Krijnen P, Bartelink A, et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data. J Hypertens Suppl 1998;16:S21–7.

    PubMed  Google Scholar 

  9. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329–35.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085–98.

    Article  CAS  PubMed  Google Scholar 

  2. Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071–84.

    Article  CAS  PubMed  Google Scholar 

  3. Pfeffer MA, Burdmann EA, Chen CY, et al., TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361:2019–32.

    Article  PubMed  Google Scholar 

  4. Szczech LA, Barnhart HX, Inrig JK, et al. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 2008;74:791–8.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Bijkerk CJ, de Wit NJ, Muris JW, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009;339:b3145.

    Article  Google Scholar 

Literatur

  1. Holmes DR, Reddy VY, Turi ZG, et al., PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Club. Med Klin 105, 111–117 (2010). https://doi.org/10.1007/s00063-010-1015-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-010-1015-5

Search

Navigation